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A B S T R A C T   
Background: In a biological environment, nanoparticles are rapidly coated with serum proteins, 
which affects the NPs transport through biological medium, cellular uptake and response, all of 
which can impair therapeutic efficiency. Reduction of non-specific adsorption of proteins is 
mandatory to overcome this drawback. 
Aim: We propose to use albumin to prepare a multilayer coating of NPs to reduce the non-specific 
protein interactions in biological media. 
Materials & methods: Biohybrid NPs (bioHNPs) prepared by coating gold NPs with a multilayer of 
albumin and finally decorated with Bombesin-related peptides (BD-bioHNPs). 
Results: BioHNPs/biological media interaction was characterized by physicochemical and bio-
logical techniques under near-physiological conditions. A significant reduction of the Corona ef-
fect and enhanced in vitro uptake to PC-3 cells was demonstrated for BD-bioHNPs. 
Conclusion: This methodology to prepare decorated bioHNPs allows the preparation of ‘stealth’ 
NPs with improved cell targeting and the ability to avoid non-specific interactions with the 
biological media.   
1. Background 
A 2018 report on the worldwide burden of disease for cancer estimated the number of new cancer cases at 18.1 m [1]. This 
staggering figure is compelling enough to have launched many investigations on therapeutic drug design strategies related to diag-
nosing and treating this disease. Although significant advances have been made in these fields, at present, none of the existing 
therapies can cover all cancer variants, which differ in their histopathological characteristics and their genetic variations [2]. Besides, 
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many of the available drugs are unable to reach the site of metastases [3]. 
Approaches based on nanotechnology for the development of novel therapeutic and diagnostic strategies are currently under study. 
In addition, the use of inorganic materials proposed by nanotechnology opens new alternatives based on the properties of high atomic 
weight elements at the nanoscale. Nanomaterials are endowed with the unique optical and magnetic characteristics of inorganic 
nanomaterials, which renders them ideal candidates for cancer therapy [4,5], imaging [6,7], and potential theranostic tools [8–10]. 
Nanoparticles (NPs) are the most widely studied nanomaterials for nanomedicine applications. There is an abundant body of 
literature on NP targeting using surface immobilization of different molecules such as vitamins [11,12], peptides [13,14], proteins 
[15], oligonucleotides [16,17], among others. In addition, these nano-constructs have demonstrated selectivity for specific cell tar-
geting using in vitro cell cultures, running binding experiments in the absence of proteins in the media. However, it is well-known that 
NPs prepared from inorganic materials and polymers rapidly get coated by serum proteins in a biological environment. This dynamic 
and complex coating process is called the Corona effect [18,19]. One of the main issues pertaining to this process is that it affects the 
transport of NPs through biological media and cellular uptake, including the cellular response, which can impair therapeutic efficiency 
significantly [20]. This phenomenon can be explained by thermodynamics, since energy-favored protein binding reduces enthalpy, 
and the displacement of the hydration layer increases entropy. The consequences of such bio-nano interactions are the increment in the 
nanoparticle solubility and the possible onset of the biophysical processes of protein misfolding and aggregation. Therefore, the Corona 
effect masks the chemical or biological functionalities imparted to the NP prepared in the laboratory [21]. The inability to control the 
NP transport inside the body poses a significant limitation for using nanotechnology to diagnose and treat cancer [22]. 
Regarding the different materials available for NP preparation, protein-based NPs have shown high biocompatibility and those 
prepared from albumin have been approved for human therapeutic use [23]. Albumin-based NPs have been designed on account of 
their various clinical uses, among them, as nano-vehicles in a drug delivery system. Such choice relies on the fact that albumin 
constitutes approximately 50% of the proteins present in the plasma of healthy individuals. This multifunctional protein can bind to 
and transport numerous endogenous and exogenous compounds. Moreover, it is found in large amounts in the circulatory system and 
extracellular space; however, it is absent in the cell cytoplasm. It is a protein with high biocompatibility and biodegradation to single 
amino acids [24]. The highlight of albumin-based NPs for the pharmaceutical industry was the conjugation of nanoparticle 
albumin-bound Paclitaxel (Abraxane®), which avoids some toxicities associated with solvent-bound Paclitaxel. This NP does not have 
any specific ligand decoration for targeting; nevertheless, some accumulation in tumors has been described by the ‘Improved 
permeability and retention effect,’ also called EPR [25]. Years later, this phenomenon generated controversies in the scientific 
community since studies show contradictory results [26,27]. 
More than one decade after the approval of Abraxane®, few advances have been made to improve the selectivity of this nanocarrier 
to in vivo address tumor cells by decoration with specific ligands. One possible explanation can be found in the non-covalent in-
teractions between its components, which allow albumin exchange with the milieu. Therefore, any NP decoration will be lost from 
their surface when NPs are injected into the bloodstream. A recent review stresses the importance of endowing a ‘biological identity‘ to 
synthetic NPs as an approach to improve the crosstalk with the biological milieu [19]. However, to the best of our knowledge, there are 
no procedures for preparing stable ‘stealth’ nanoparticles based on albumin. 
Early in the bio-nanotechnology era, it was reported that pre-coating the polystyrene nanosphere with albumin reduces their in vivo 
receptor-mediated hepatic disposition [28]. However, the dynamic exchange process between the biological media and non-covalent 
nano-constructs, such as pre-coating or aging NP surface with proteins, spoiled the idea of proteins as coating molecules. Protein gold 
NPs interactions occur spontaneously, increasing their colloidal stability. However, this interaction is not covalent, and proteins are 
released from the surface and exchanged with the milieu in proteinaceous media. Besides, proteins can modify their conformation 
through interaction, and they could adopt a different conformation after being released. It has been demonstrated that albumin is 
‘spread’ onto the gold surface, where at least 12 Au-thiol bounds contribute to albumin binding. The high flexibility of the albumin 
structure allows significant changes on its surface [29]. Therefore, in addition to the protein exchange effect, the AuNPs coated with a 
monolayer of albumin (MNPs) will expose a different topography to the medium even if it is the same protein; with a consequent loss of 
the native conformation, as it has been schematized in MNPs of Fig. 1 scheme. It is important to stress the fundamental importance of 
Fig. 1. Scheme of monolayer albumin coating of AuNPs (MNPs) and multilayer albumin coating of AuNPs (bioHNPs).  
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protein folding in its biological functionality (in this case, protein-protein interactions). Unfolded proteins or those incorrectly folded 
will lead to protein malfunction in living systems and biological disorders [30]. To overcome this drawback, gold NPs can be coated 
with a crosslinked multilayer of albumins as a strategy to produce a highly compact protein shell preserving the albumin surface of the 
most external layer of the nano-construct, as it is schematized in Fig. 1. Albumin multilayer coating is performed by the 
radiation-induced crosslinking method [31]. 
In addition to the compatibility of the bioHNPs with proteinaceous milieu, the nano-construct should be decorated for precise cell 
targeting. A specific interaction of NPs with cells is essential to develop theranostic tools which can overcome the existing limitations in 
the delivery of nanostructures [32,33]. Labeled peptides are currently used for in vivo detection of cells containing specific membrane 
receptors for them [34]. Therefore, the decoration of NPs with particular peptides and the study of the cell-NPs interactions by in vitro 
experiments are essential checkpoints for the reduction of the Corona effect and finally for the development of a nanomedicine 
application. 
In this report, bioHNPs containing a gold core and a crosslinked multilayer shell of albumins are prepared and characterized in 
proteinaceous media. Decoration of bioHNPs with a Bombesin-related peptide allows the study of cell uptake in complete media to 
demonstrate the benefits of the albumin multilayer coating and the specific labeling for cell targeting. 
2. Methods 
Synthesis of gold nanoparticles: AuNPs were prepared according to the Frens method [35]. The concentration of AuNPs was 
determined through UV–vis spectroscopy, according to Flores et al. [36]. 
Preparation of hybrid gold/albumin nanoparticles (bioHNPs): AuNPs (500 µl, 0.1 mM) were dispersed in a mixture of BSA/HSA (1 ml) 
with the final concentration of 30 mg ml− 1 of BSA and 15 mg ml− 1 of HSA under stirring conditions. After that, absolute ethanol (600 
µl) was added dropwise onto the gold/protein solution, keeping the temperature at 0 ◦C under constant stirring. The final concen-
tration of ethanol was 30%v/v. The mixture of ethanol, protein, and AuNPs was irradiated with gamma-rays from a 60Co source (PISI 
CNEA-Ezeiza) at a 10 kGy dose and at a dose rate 1 kGy h− 1 and the temperature of the sample was kept in the range of 5–10 ◦C during 
the irradiation. 
After irradiation, samples were diluted to a suitable concentration with Milli-Q water for different experiments. NPs were 
centrifuged (13,000 rpm, 15 min at 4 ◦C), dispersed in Milli-Q water, and treated with 0.05% glutaraldehyde by stabilization, 
following, were purified by size-exclusion chromatography as is described previously [37]. The purified NPs were separated by 
Vivaspin® 500 centrifugal concentrator 100,000 MWCO, and free albumin released from bioHNPs was determined by Bradford assay 
in the supernatant. 
In the case of monolayer gold/albumin nanoparticles (MNPs), AuNPs (500 µl, 0.1 mM) were dispersed in a final concentration of 1 
mg ml− 1 of protein. These NPs were not irradiated. Instead, MNPs were purified by centrifuging (13,000 rpm, 15 min at 4 ◦C) and 
dispersed in Milli-Q water. 
Functionalization with synthetic peptide Bombesin-DOTA: bioHNPs were incubated in a solution of glutaraldehyde at 0.02% freshly 
prepared in Milli-Q water. The activated bioHNPS were incubated ON with BD at a final concentration of 0.2 mM at room temperature. 
After incubation, the excess of reagents was removed by Sephadex G-25 (prepacked columns PD-10, GE Healthcare). This desalting 
column was applied to remove the excess BD. 
In vitro protein corona protocol: AuNPs, MNPs, and bioHNPs were incubated in fresh RPMI 1640 medium supplemented with 10%v/v 
FBS and 0.5 mg ml− 1 of HSA. The incubation temperatures tested were at 4 h and 24 h, at 37 ◦C and under a 5% CO2 atmosphere, 
simulating cell culture conditions. After the incubation, the samples were centrifuged (13,000 rpm, 4 ◦C) for 20 min and dispersed in 
water Milli-Q. Using DLS and TEM, sample analysis was performed, comparing the results with the NPs without incubation with FBS. 
In vitro study of the NPs interaction with PC-3 cells: Cell culture and NP uptake were performed onto PC-3 cell line (American Type 
Culture Collection) and maintained in RPMI growth medium at 37 ◦C in controlled CO2 atmosphere of 10% v/v FBS (Internegocios, 
Argentina). The NPs tested were the MNPs and bioHNPs with and without the BD peptide-decoration. For NPs uptake, the protocol 
developed by Tkachenko et al. was followed [38]. Cells (2 × 105) were seeded in glass coverslips in 24-well plates ON, and after that, 
incubated with NPs conjugates (10 pM) for 4 h in the same culture condition. All studies were performed using RPMI media sup-
plemented with 10% FBS and HSA (0.5 mg ml− 1 final concentration). NPs were diluted in the same media. For fluorescence detection 
experiments, NPs were labeled with NHS ester BODIPY 630/650. 
Confocal microscopy pictures were captured with Olympus FV300/BX61 microscope, using sequential Blue Argon (488 nm), Red 
Helium-Neon (633 nm) excitation lasers, and cut-off emission filters 520/10 and 660, respectively. This combination avoids any 
possibility of overlapping probes. Olympus Fluoview FV1000 Viewer was used for the analysis of the pictures. Cells were grown onto a 
coverslip, and after NP incubation, they were rinsed with phosphate-buffered saline (PBS, 10 mM, pH 7.4) extensively. Then, cells were 
fixed with 4% paraformaldehyde in PBS for 15 min at 37 ◦C and rehydrated in PBS before microscopy analysis. Finally, Syber Green or 
DAPI was used to stain the cell nucleus. 
Flow cytometry analyses were performed with a BD FACSCalibur® cytometer. Briefly, the cells were incubated with a final con-
centration of 10 pM of NPs for 1 h or 4 h. After incubation, the cells were washed twice with sterile PBS before analysis. For this assay, 
the NPs were labeled with the Bodipy FL NHS ester 502/508 chromophore. Data acquisition and analyses were performed using the BD 
CellQuest Pro-software package. Flow cytometry analyses were carried out by recording 20,000 events and the fluorescence in the FL1 
(530/30 nm band-pass filter) channel was analysed. Three independent assays were performed, and the geometric fluorescence media 
in the FL1 histogram was calculated.  The statistical analysis was performed using Graph Pad Prism v6.0 software. The differences 
between MNPs versus bioHNPs at 37 ◦C were analyzed by a two-way ANOVA followed by a post-test of multiple Sidak comparisons. 
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Labeled NPs-fluorescence of the different samples was compared as in fluorescence per NP to rule out the possibility that the fluo-
rescence variations found in the cells were due to differences in the NPs labeling. 
3. Results 
The BioHNPs employed in this work were prepared by a novel method, which is less harsh than the well-established process of 
desolvation by organic solvents. The AuNPs employed in this work were incubated in HSA solution (15 mg ml− 1), and ethanol was 
added up to 30%v/v keeping the temperature below 5 ◦C throughout the process. This amount of ethanol has previously been reported 
to induce reversible albumin aggregation [39]. It is crucial to monitor the aggregation conditions carefully in order to avoid irre-
versible protein denaturation, like Cohn’s fractionation of HSA from human sera. In the next step, the NPs were stabilized covalently by 
a radiation-induced crosslinking method [39,40]. The crosslinking reaction is based on the protein macro radical recombinations 
generated by solvent radiolysis [41]. Albumin-NPs are generated simultaneously in addition to bioHNPs [36]. Therefore, a purification 
protocol including centrifuging and size-exclusion chromatography steps was required to prepare a homogenous and stable batch of 
bioHNPs. 
The characterization data corresponding to the bioHNPs and MNPs is summarized in Figs. 2 and 3. The shape of the plasmon and 
protein absorption peaks of AuNPs, MNPs, and bioHNPs were compared by means of UV–vis spectra (Fig. 2). BioHNPs spectrum clearly 
showed an absorption peak at 280 nm corresponding to the albumin coating and a maximum plasmon shift to 530 nm produced by the 
protein coating [36]. Theoretical simulations of Mie theory considering a steady coating model have explained the changes in the 
plasmon extinction. In this model, all NPs will have the same coating thickness for an experimental condition, regardless of the naked 
NP radii [36]; therefore, the coating process did not increase the heterogeneity of the NP size population. Dynamic light scattering 
(DLS) measurements of MNPs and bioHNPs showed a mean hydrodynamic diameter (HD) of 28.02 +/- 0.6 nm and 77.4 +/- 0.7 nm, 
respectively (Fig. 3A and 3B). Transmission electron microscopy (TEM) measurements were performed to assess their properties and 
morphology (Fig. 3). The TEM images of bioHNPs revealed well dispersed NPs of the following dimensions: NP core diameter 14 +/- 3 
nm and a ‘light grey’ corona with a diameter of 32 +/- 7 nm corresponding to the uranyl stain of the albumin multilayer coating 
(Fig. 3B). The significant difference between the HD and the diameter measured by TEM could be explained by the hydration of al-
bumin in the coating shell. Fig. S1 shows TEM pictures of bioHNPs at different magnifications. 
The ζ-potential of bioHNPs in phosphate buffer was  –12.1 +/- 1.2 mV, which is close to MNPs (–15.0 +/- 1.0) and that corre-
sponding to BSA (–18.0 mV) in the same buffer condition (Table S1) [42]. These values are characteristic of proteins and far from those 
corresponding to inorganic nanoparticles (ζ-potential of AuNPs –38.8 +/- 0.8 mV), reinforcing the hypothesis that the nanoparticle 
surface will behave quite like a protein surface. Further characterization of bioHNPs by Infrared Spectroscopy, SDS-Page electro-
phoresis, and AFM is included in the Supporting Information (Fig. S2 to S4). Circular Dichroism Spectroscopy analysis of the protein 
coating demonstrated that albumin kept its secondary structure almost entirely (Fig. S5). 
The shell stability of bioHNPs depends on the albumin released by them, which was determined onto a purified fraction of NPs. 
Free albumin concentration was below the detection limit of the Bradford assay (3 µg ml− 1) of albumin. This value corresponded to less 
than 50 albumin molecules per single bioHNP. 
NP stability was studied in a high-salt medium across the changes of the plasmon signal. Coated NPs showed higher stability than 
naked ones up to NaCl 3 M, as can be seen in Fig 4. Both coated NPs (MNPs and bioHNPs) were stable in the studied NaCl range; 
Fig. 2. UV–vis spectra of AuNPs, AuNPs with a monolayer coating of albumin (MNPs) and AuNPs with a multilayer albumin coating (bioHNPs).  
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however, the absorbance ratio at 520 nm/650 nm or 530 nm/650 nm was slightly different between MNPs and bioHNPs. This dif-
ference stemmed from the changes in the refraction index and thickness of the protein coating layer [36]. 
In order to study biocompatibility by in vitro experiments, the three NPs were compared in terms of interactions with proteins of a 
biological medium. Serum proteins stick to NPs when they are dispersed in a proteinaceous medium, forming a protein crown and 
conferring a new biological identity to them. Therefore, it is essential to analyze the protein corona formation before studying the NP 
interaction with living cells under realistic conditions. 
Considering that most of the blood proteins have HDs between 3 nm and 15 nm and NPs have a round shape, it will be possible to 
assume a protein corona effect by measuring changes in the HD of the NPs. AuNPs (citrate coated), MNPs, and bioHNPs were incubated 
in a biological media for 4 h and 24 h and changes in HDs were measured. The biological media model used was cell culture media 
(RPMI media, supplemented with FBS 10%v/v). After removing the vast amount of free protein by centrifuging, the NPs pellet was 
resuspended in water, and the HDs were measured by DLS. As expected, AuNPs and MNPs showed a considerable increase in their HDs 
(250% and 49% respectively at 24 h), while bioHNPs did not present a statistical difference in their HD after the incubation during 4 or 
24 h. Table 1 summarizes the HD values obtained for all the NPs samples before and after incubation in the biological media. The 
Corona effect was clearly visible under TEM microscopy. Pictures of NPs after the incubation in the biological medium are shown in 
Fig. 5. Proteins were visualized by being stained with uranyl acetate. In the case of bioHNPs, it is interesting to observe a lower staining 
of the protein multilayer coating than that of the free protein present in the sample. 
BioHNPs showed low binding to non-specific proteins, so their surface functionalization must ensure cell-recognition properties. 
For this purpose, bioHNPs were decorated with the Bombesin-related peptide (BD) (see Fig. 6A), and cell targeting was evaluated on in 
vitro cell culture. BD targets tumor cells containing overexpressed gastrin-release peptide receptor (GRPr), such as the PC-3 cell line 
[43]. Considering the potential pharmaceutical applications, BD also contains a chelating DOTA moiety, which allows the chelation of 
therapeutic radioisotopes. 
The decoration of bioHNPs was performed using the homo-bifunctional reagent glutaraldehyde. The presence of aromatic amino 
acids in the BD allowed the visualization of the NPs-decoration by UV–vis spectroscopy (Fig. 6B). In addition, BD was determined in 
Fig. 3. Size analysis of the A) MNPs and B) bioHNPs by Dynamic light scattering (DLS) and Transmission electron microscopy (TEM). Arrows 
indicate the multilayer albumin coating. 
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terms of its ability to chelate one Pb(II) atom per DOTA moiety. Functional BD was quantified by trans-chelation of Pb(II) [44] 
following detection by Total reflection X-rays fluorescence (TXRF). This analysis also determined the content of Au and albumin by S 
(considering there are 35 S atoms per albumin). TXRF results showed at least 60 times more albumin in bioHNPs than MNPs, 
considering all NPs were prepared from the same AuNPs batch. Moreover, the Pb(II) measure determined around 2600 BD molecules 
Fig. 4. Stability of nanoparticles at different NaCl concentrations. (A) Naked (Citrate coated) AuNPs; (B) MNPs and (C) bioHNPs. (D) Evolution of 
Absorbance ratio (520 nm/650 nm or 530 nm/650 nm) with the NaCl concentration. 
Table 1 
The hydrodynamic diameter of AuNPs, MNPs, and bioHNPs before and after incubation in a biological media incubation (RPMI +
10% SFB) during different incubation times. Measurements were done in milliQ water after the centrifugation step.   
Incubation time* NP diameter† Increment 
(h) (nm) +/- 1 SD (%) 
AuNPs 0 21.2 +/- 1.1   
4 78.8 +/- 5.3 273  
24 74.2 +/- 6.5 251 
MNPs 0 35.5 +/- 1.5   
4 54.5 +/- 2.9 54  
24 52.9 +/- 3.1 49 
bioHNPs 0 77.4 +/- 7.0   
4 75.5 +/- 4.4 0  
24 76.1 +/- 3.3 1  
* ) NPs were incubated in fresh RPMI 1640 medium supplemented with 10%v/v FBS and 0.5 mg ml− 1 of HSA at 37 ◦C and under a 
5% CO2 atmosphere. 
† ) Diameter determined by DLS after the centrifugation step (13,000 rpm, 4 ◦C) for 20 min to remove the culture media and 
dispersed in water milliQ. 
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per NP (Table S2). The final size of the nano-construct showed a 20 – 30 nm increase in the diameter concerning non-BD-decorated 
bioHNPs (see Fig. S6), confirming the final nano-construct was not oversized. 
The study of the biological interaction of prepared NPs with cells was performed by confocal laser-microscopy and flow cytometry 
analysis using in vitro cell cultures. The choice of model of NPs targeting through Bombesin/GRP receptor interaction was PC-3 cells, 
which are prostatic tissue cells which grow adherently in a cellular monolayer and have an epithelial morphology [45]. Cell uptake 
experiments were performed using fluorescent NPs labeled with the chromophore Bodipy 630/650. PC-3 cells were incubated with a 
final concentration of 10 pM of NPs per well in RPMI culture medium supplemented with 10% FBS and 0.5 mg ml− 1 HSA. After 
four-hour incubation at 37 ◦C, cells were rinsed, fixed, and examined by microscopy. 
The left column of Fig. 7 shows a comparison of confocal images of PC-3 cells incubated with four types of NPs: MNPs, BD-decorated 
MNPs (Fig 7A and 7B), bioHNPs and BD-decorated bioHNPs (Fig 7C and 7D) .The nuclei of PC-3 cells are DAPI stained, and red in-
dicates the labeled NPs within the cytoplasmic region. The right column of Fig. 7 shows flow cytometry analysis of statistical data on 
the uptake. 
As can be seen in Fig. 7, cells incubated with the BD-decorated NPs showed more significant red fluorescence when compared to 
those incubated with non-decorated ones, which suggests cells are not only interacting but also internalizing the peptide signaling. In 
addition, BD-bioHNPs showed higher fluorescence signal than BD-MNPs. This difference can be clearly visualized in low magnification 
images (10X) in Fig. S7, which shows pictures corresponding to BD-decorated MNPs and bioHNPs. 
NPs/cell interaction observed was minimal for the MNPs (Fig. 7A) and bio-HNPs without peptide decoration (Fig. 7C). In contrast, 
when NPs were decorated with BD (BD-MNPs and BD-bioHNPs), cell fluorescence values increased, which indicated the presence of 
NPs. The maximum fluorescence was reached after 4 h of incubation. Regarding the incubation time, the uptake of BD-MNPs required 
at least 2 h to be completed while the uptake of BD-bioHNPs reached its maximum at 1 h. In addition, it was the highest amount of NPs 
internalized. 
The statistical analysis of flow cytometry study, obtained from three independent determinations, is shown in Fig. S9. After 1 h of 
incubation MNPs, with or without BD, the result was a significantly different interaction with a p ≤ 0.001. After 4 h, this difference 
increased with higher significance (p < 0.0001). In the case of bioHNPs, there was a much higher geometric media shift after 1 h 
Fig. 5. TEM pictures of naked AuNPs; (B) MNPs and (C) bioHNPs after the incubation in the biological medium. Arrows indicate the multilayer 
albumin coating. (D) DLS of bioHNPs after the incubation in the biological medium. 
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incubation time had elapsed. No significant differences were found between non-decorated MNPs and bioHNPs. Both confocal laser 
microscopy and flow cytometry showed that BD-bioHNPs are the nano-construct that best interacts with PC-3 cells in similar con-
ditions in a biological environment (culture medium with a high concentration of serum proteins). 
In order to observe the uptake of NPs in PC-3 cells, phase-contrast microscopy was employed. Cells were incubated for 4 h with a 
small amount of NPs (1 pM concentration) of the coated NPs in the monolayer form (MNPs and BD-MNPs) or the hybrid ones (bioHNPs 
and BD-bioHNPs). Fig. S8 shows selected images of phase-contrast microscopy of cells containing NPs (black dots indicated with 
arrows). Cultures incubated with BD-MNPs showed NPs near the cell membrane (Fig. S8B). In the case of BD-bioHNPs (Fig. S8D), they 
were mainly spread in the cytoplasm region. 
It is well-known that low temperature can inhibit endocytosis mechanisms [46] so to determine if the endocytic process was 
energy-driven, NPs cell uptake assays were performed at 5 ◦C.  The interaction was found to be much lower than that observed at 37 ◦C 
(see Fig. S10) with a statistically significant difference (p ≤ 0.0001). The assays were performed in the presence of 10% SFB and HSA to 
the incubation medium during treatments with BD-bioHNPs. 
Recently, cytotoxicity studies of different AgNPs [47] and SiO2 NPs [48] on lymphocytes and monocytes from human blood (PBMC) 
have been reported as model biocompatibility assays. For this reason, the interaction of bioHNPs with PBMC was assessed by means of 
flow cytometry as a complementary in vitro study of the biocompatibility of these NPs. The flow cytometry analysis showed no 
interaction after four hours’ incubation time (Fig. S11). In this experiment, DB-bioHNPs (i.e. those decorated with Bombesin-DOTA) 
were not included in the assays because it is known that lymphocytes have GRP receptors on their membranes [49], and some 
interaction was to be expected. 
Cell viability and possible cytotoxic effects on PC-3 cells of non-decorated MNPs and bioHNPs were evaluated by an MTT assay. 
Cells were incubated at 4, 24, and 48 h with different MNPs and bioHNPs concentrations (Fig. 8). In all studied conditions, no cytotoxic 
effects were observed with one exception. A significant decrease in metabolic activity (and therefore cell viability) was observed in 
cells incubated with MNPs for 48 h at the highest concentration tested (100 pM). In addition, MNPs aggregation was observed in these 
wells. 
Finally, a human red blood cell hemolysis assay was carried out to evaluate the biocompatibility of non-decorated MNPs and 
bioHNPs. Cells were incubated for 4 h with different concentrations of NPs. As a result, no toxicity was observed for any of the 
conditions and times tested for bioHNPs (see Fig. S12). Low toxicity was determined after incubation with 40 pM of MNPs. 
4. Discussion 
Albumin is the major protein in the human blood, and it is also a commercially available product. These two characteristics allow us 
to use this biomacromolecule as a building- block to prepare bio nanosystems for nanomedicine. 
The ideal NP to create injectable nanomedicines should have low non-specific interacting properties with the biological envi-
ronment. This feature has proved to be one of the biggest challenges to achieve experimentally. As was mentioned above, albumin has 
several biological attributes to be used as ‘the surface’ of the nano-construct. In the past, NP coating with albumin showed biological 
Fig. 6. (A) Scheme of Bombesin-DOTA peptide (BD) used to decorate the bioHNPs and (B) UV–VIS spectra corresponding to bioHNPs and BD- 
decorated bioHNPs. 
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Fig. 7. Confocal microscopy (left column) and flow cytometry histograms (righ column) of PC-3 cells after incubation with fluorescent-labeled NPs. 
Confocal microscopy was performed after 4 h of incubation at 37 ◦C with 10 pM (60X magnification) and flow cytometry histograms of PC-3 cells 
incubated with 10 pM of NPs at 37 ◦C for 1 h (fuchsia) and 4 h (orange) of: A) MNPs; B) BD-MNPs; C) bioHNPs; and D) BD-bioHNPs. (For 
interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) 
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improvements in most in vitro and in vivo studies [28,50,51]. However, precoating or aging nanoparticle surfaces with proteins (e.g., 
clustering or serum albumin) could confer NP with stealth properties, but targeting capacity would be reduced [21]. 
Pharmaceutical technology employed various techniques to prepare hybrid NPs, including covalent conjugation and physical 
entrapment via coating, spray drying or desolvation, which is one of the most widely applied methods [52]. Desolvation generates a 
multilayer protein coating in the shape of a core-shell fashion but the high concentration of ethanol or acetone used to yield stable 
nanostructures can induce protein denaturation [52]. Attention must be paid to the conformational change of macromolecules in the 
nanostructure though unfortunately to the best of our knowledge, there is little in the existing literature on this aspect. Therefore, if this 
method is used, the NP surface will not resemble folded albumin in its native state. 
In our work, the preparation of BioHNPs was carried out with emphasis on the conservation of the native structure of the most 
superficial albumins. The multilayer albumin coating of AuNPs prepared by radiation-induced crosslinking method and chemical 
stabilization allowed a negligible HD increment under proteinaceous media. A similar protein corona experiment performed in the 
literature using PEG functionalized AuNPs showed a much greater interaction, given that the NP’s HD increased by 50% after 24 h 
incubation in serum [53]. 
Decorated NPs allow targeting of a specific cell type. However, NPs exposed to living cells in a biological medium can be inter-
nalized by several mechanisms [54]. Passive internalization occurs without energy requirements or the intervention of receptors. This 
type of interaction is not selective, so it would not be helpful for targeted therapies. In contrast, decorated bioHNPs can make entry 
through energy-driven mechanisms, such as endocytosis. 
As regards the biological system, BD/GRP receptor, PC-3 cells have been reported as having one unique type of binding site with a 
high affinity to Bombesin (Kd 9.8 × 10− 11 M) and a binding capacity of 44,000 sites/cell [43]. Therefore, assuming one NP interacts 
with a dozen membrane receptors in the endocytosis process, the quantity of NPs to saturate the receptors of one cell will be in the 
order of 102–103 NPs. The in vitro cell uptake assay performed in this work was designed with an average of 2 × 105 cells per well and a 
maximum of 108–109 NPs per well to avoid receptor saturation. The experimental NP concentration was set between 1 and 10 pM, 
which corresponds to a total amount of NPs in the range of 6 × 107 to 6 × 108. Thus, the NP/cell ratio was between 300 and 3000 
NPs/cells, much lower than the number of GRP receptors. These refined experimental conditions allowed the maximum uptake 
expression under non-saturating conditions and avoided NPs overloaded experiments. 
Results from confocal microscopy and flow cytometry demonstrate the enhanced uptake process of BD-bioHNPs. In addition, taking 
into account the dissociation constant of Bombesin for GRPr is in the order of 1–10 nM [43,55] and the experiments performed above 
using pM concentration of bioHNPs, it is possible to speculate that the avidity of the NPs decorated with BD is, at least, three orders of 
magnitude higher than that of the free peptide (at 37 ◦C). In addition, bioHNPs showed lower cytotoxicity for a longer time than MNPs. 
The information given in this work might become extremely useful for those working on nanoparticle design as a cornerstone for 
the development of future applications in medicine. Remarkably, the strategy of multilayer protein coating can be extrapolated to 
other inorganic NPs to improve biocompatibility by reducing the Corona effect, enhancing ligand/receptor recognition for cell tar-
geting and reducing unwanted cytotoxicity. 
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